← Insider buys
SPRO

Spero Therapeutics, Inc. · Healthcare

COO Timothy Keutzer sold $44K of Spero Therapeutics, Inc.

Sold$44,019
$2.36Price
18,652Shares
−2%Stake

What SPRO did after the filing

Filed Feb 9Copier in Feb 10
The stock from Tue, Feb 10 open, $2.40
+0.4%
S&P 500, same days
−5.5%

Measured over 30 trading days, to the Mar 25 close.

Traded Fri, Feb 6. Filed Mon, Feb 9, 4:09 PM ET, after the close. Returns use the Feb 10 open and the Mar 25 close. Not investment advice.